Kevin Robert Lind - 08 Feb 2024 Form 4 Insider Report for Longboard Pharmaceuticals, Inc.

Role
CEO, Director
Signature
/s/ Andrew J. Cronauer, Attorney-In-Fact
Issuer symbol
N/A
Transactions as of
08 Feb 2024
Net transactions value
$0
Form type
4
Filing time
09 Feb 2024, 16:06:55 UTC
Previous filing
10 Feb 2023
Next filing
13 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LBPH Stock Option (Right to Buy) Award $0 +332,134 $0.000000 332,134 08 Feb 2024 Voting common stock 332,134 $19.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the stock option vest and become exercisable in 48 equal monthly installments commencing March 8, 2024.